Sorry Rappers, page-127

Actually industry insiders in the medical field will tell you Australia is a popular market for global biomedicals to initially product launch into

It has similar infrastructure to other countries , a good health care system, good regulatory process , and given its size a great way to product launch , smooth out any pricing , marketing ,customer and product issues , prior to any refining for launching to the bigger Europe and USA markets upon their regulatory approval

Going straight to USA for a FDA approval is higher risk , you stuff the results up like RAP did and now the industry loses confidence in whether it practically can work and is reliable , USA market is high exposure so it will be well known what has occurred

Any approval submission which is now no time soon will be met with a high degree of scrutiny of the results .